Innocoll AG Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Innocoll Holdings - Ordinary Shares (MM) INNL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.35 19:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
2.00 2.45 0.45 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.35 USD

Innocoll AG Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 929.18M 395.40M 395.40M $ 4.37M $ - -0.16 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.80%

more financials information »

Innocoll AG News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INNL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Innocoll AG Description

Innocoll AG was incorporated in Delaware under the name Innocoll, Inc. in December 1997 and renamed Innocoll Holdings, Inc., in May 2004. In July 2013, Innocoll Holdings, Inc., was re-domiciled from the United States to Germany pursuant to a contribution-in-kind and share for share exchange into the recently formed Innocoll GmbH, a German limited liability company, as a result of which Innocoll Holdings, Inc. became Innocoll GmbH's wholly-owned subsidiary. The Company is a commercial stage specialty pharmaceutical company, with late stage development programs targeting areas of significant unmet medical need. The Company's product candidates are XaraColl for the treatment of post-operative pain and Cogenzia for the treatment of diabetic foot infections. XaraColl, is an implantable, bioresorbable collagen sponge designed to provide sustained post-operative pain relief through controlled delivery of bupivacaine at the surgical site.

Your Recent History
Innocoll ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.